Related Experiment Video
Updated: Jul 9, 2025

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Efficiently Differentiating Agonists and Competitive Antagonists for Weak Allosteric Protein-Ligand Interactions with
Anthony J Davolio1, Wojciech J Jankowski1, Csilla Várnai2,3
1Theory of Condensed Matter Group, Department of Physics, University of Cambridge, Cambridge CB3 0HE, U.K.
Abstract:
What makes an agonist and a competitive antagonist? In this work, we aim to answer this question by performing parallel tempering Monte Carlo simulations on the serotonin type 3A (5-HT3A) receptor. We use linear response theory to predict conformational changes in the 5-HT3A receptor active site after weak perturbations are applied to its allosteric binding sites. A covariance tensor is built from conformational sampling of its apo state, and a harmonic approximation allows us to substitute the calculation of ligand-induced forces with the binding site's displacement vector. Remarkably, our study demonstrates the feasibility of effectively discerning between agonists and competitive antagonists for multiple ligands, requiring computationally expensive calculations only once per protein.
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Cooperative Allosteric Transitions
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Allosteric Regulation

